Vaso Active Pharmaceuticals (VAPH) 10QSB Quarterly report (small business)

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Vaso Active Pharmaceuticals, Inc.(the “Company”) on Form 10-QSB for the three month period June 30, 2004, as filed with the Securities and Exchange Commissio n on the date hereof (the “Report”), I, Joseph Frattaroli, Chief  Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Joseph Frattaroli
Chief Financial Officer (principal financial officer)
August 9, 2004

This certification is made solely for purpose of 18 U.S.C. Section 1350, subject to the knowledge standard contained therein, and not for any other purpose.